Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib in HGPS and Progeroid Laminopathies
NCT00425607Phase 2Completed
- Start
- May 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lonafarnib in Hutchinson-Gilford progeria syndrome (HGPS), progeroid laminopathy. Started May 2007; status: completed.
02
Drugs
lonafarnib
03
Conditions
Hutchinson-Gilford progeria syndrome (HGPS)progeroid laminopathy
Beyond the preview
Go deeper on NCT00425607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425607.